LEADER 00752nam a22002173a 4500 001 991003834499707536 005 20241212094917.0 008 080730s 000 0 eng d 020 $a8831750666 035 $ab13758718-39ule_inst 040 $aDip.to Lingue$bita 100 $aPanaccione, Andrea$0173683 245 00$aMay Day Celebration /$cAndrea Panaccione 260 $aVenezia :$bMarsilio,$c1988 300 $a214 p. ;$c22 cm 907 $a.b13758718$b28-01-14$c30-07-08 912 $a991003834499707536 945 $aLE012 Fondo Commonwealth 4-3-07$g1$i2012000306189$lle012$o-$pE0.00$q-$rn$so$t0$u0$v0$w0$x0$y.i14813038$z30-07-08 996 $aMay Day Celebration$91228231 997 $aUNISALENTO 998 $ale012$b30-07-08$cm$da$e-$feng$git$h0$i0 LEADER 01064nam0 22002651i 450 001 UON00068410 005 20231205102340.484 100 $a20020107d1989 |0itac50 ba 101 $aeng 102 $aUS 105 $a||||m ||||| 200 1 $aˆA ‰linguistic analysis and evaluation of arabic textbook materials and methodology$fMohammad Ahmad Amayreh 210 $aAnn Arbor$cUMI$d1989 215 $a243 p.$d21 cm 606 $aLingua araba$xInsegnamento$3UONC018490$2FI 620 $aUS$dAnn Arbor (Michigan)$3UONL000025 676 $a492.7$cLINGUA ARABA$v21 700 1$aAMAYREH$bMohammad Ahmad$3UONV042381$0657280 712 $aUMI$3UONV245796$4650 801 $aIT$bSOL$c20250221$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00068410 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI II C 009 $eSI AA 11290 5 009 996 $aLinguistic analysis and evaluation of arabic textbook materials and methodology$91169877 997 $aUNIOR LEADER 02534nam 2200457z- 450 001 9910557223103321 005 20211118 035 $a(CKB)5400000000041713 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/73676 035 $a(oapen)doab73676 035 $a(EXLCZ)995400000000041713 100 $a20202111d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aApplying Next Generation Sequencing and Transgenic Models to Rare Disease Research 210 $cFrontiers Media SA$d2020 215 $a1 online resource (119 p.) 311 08$a2-88963-524-4 330 $aA rare disease is a disease that occurs infrequently in the general population, typically affecting fewer than 200,000 Americans at any given time. More than 30 million people in the United States of America (USA) and 350 million people globally suffer from rare diseases. Out of the 7000+ known rare diseases, less than 5% have approved treatments. Rare diseases are frequently chronic, progressive, degenerative, and life-threatening, compromising the lives of patients by loss of autonomy. In the USA, it can take years for a rare disease patient to receive a correct diagnosis. The socioeconomic burden for rare disease is huge. For those living with diagnosed rare diseases, there is no support system or resource bank for navigating financial, educational, or other aspects of having a rare disease. The purpose of this Research Topic is to bring together leading researchers, non-profit organizations, healthcare providers/diagnostic companies, and pharma/biotech/CROs in the field to provide a broad perspective on the latest advances, challenges, and opportunities in rare disease research. 606 $aMedical genetics$2bicssc 606 $aScience: general issues$2bicssc 610 $agenetic analysis 610 $aGenomics 610 $aNext generation sequencing 610 $aRare disease 610 $atransgenic 615 7$aMedical genetics 615 7$aScience: general issues 700 $aGouw$b Arvin M$4edt$01317941 702 $aJaishankar$b Amritha$4edt 702 $aBrooks$b George A$4edt 702 $aGouw$b Arvin M$4oth 702 $aJaishankar$b Amritha$4oth 702 $aBrooks$b George A$4oth 906 $aBOOK 912 $a9910557223103321 996 $aApplying Next Generation Sequencing and Transgenic Models to Rare Disease Research$93033116 997 $aUNINA